Federated Hermes’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-145,000
Closed -$14.8M – 2349
2019
Q2
$14.8M Sell
145,000
-1,281,700
-90% -$138M 0.04% 442
2019
Q1
$162M Hold
1,426,700
– – 0.4% 44
2018
Q4
$55.8M Buy
1,426,700
+165,300
+13% +$7.17M 0.15% 138
2018
Q3
$68.8M Sell
1,261,400
-262,702
-17% -$18M 0.16% 144
2018
Q2
$126M Buy
1,524,102
+26,314
+2% +$2.03M 0.37% 58
2018
Q1
$99.7M Sell
1,497,788
-353,612
-19% -$20.4M 0.29% 71
2017
Q4
$95.2M Buy
1,851,400
+263,063
+17% +$18.9M 0.27% 72
2017
Q3
$142M Buy
1,588,337
+224,699
+16% +$17.1M 0.41% 49
2017
Q2
$81.5M Buy
1,363,638
+438
+0% +$24.5K 0.23% 81
2017
Q1
$72.7M Sell
1,363,200
-8,000
-0.6% -$475K 0.21% 89
2016
Q4
$68.4M Sell
1,371,200
-262,700
-16% -$14.1M 0.21% 97
2016
Q3
$98.1M Sell
1,633,900
-13,700
-0.8% -$790K 0.28% 61
2016
Q2
$84.2M Buy
1,647,600
+503,606
+44% +$21.5M 0.25% 74
2016
Q1
$33.8M Buy
1,143,994
+200,984
+21% +$6.34M 0.1% 167
2015
Q4
$42.7M Buy
943,010
+281,610
+43% +$14.8M 0.14% 148
2015
Q3
$27.6M Buy
661,400
+293,200
+80% +$15.3M 0.09% 229
2015
Q2
$22.2M Buy
368,200
+260,700
+243% +$17.2M 0.07% 295
2015
Q1
$8.33M Buy
+107,500
New +$6.19M 0.03% 497

Other funds holding ONCE

Federated Hermes's ONCE Position: Q3 2019 in Review

Federated Hermes sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 145,000 shares — an estimated $14.8M sold.

Federated Hermes first reported a position in ONCE in Q1 2015 and held it in 18 quarters. The position peaked at $162M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Federated Hermes reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Federated Hermes sold 145,000 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $14.8M.
  • Federated Hermes first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 18 quarters.
  • Federated Hermes's Spark Therapeutics, Inc. Common Stock position peaked at $162M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.